Beijing Court Orders Hospital to Resume Embryo Transfers for Widow

Two frozen embryos at the center of a Beijing ruling

A Beijing court has ordered a hospital to resume fertility treatment for a widow seeking to use two frozen embryos created with her husband before his death in July 2019. The ruling recognizes her right to continue an existing medical service contract, despite the hospital's argument that she no longer qualified for assisted reproduction after becoming widowed.

The woman, identified by the surname Zhang, had already used a third embryo after her husband's death and given birth to a daughter. When she later requested treatment using the remaining two, the hospital refused, citing consent requirements, possible inheritance disputes, a provision permitting embryo destruction after either spouse died, and the absence of ethics approval.

Beijing's Chaoyang District People's Court found that continuing treatment would not violate the law, the couple's agreement or ethical principles. It ordered the hospital to provide the medical services, with Zhang responsible for the personally payable portion of the related costs. The judgment has been reported as legally effective.

The court disclosed the case on September 22 when releasing its annual white paper on medical disputes. Its reasoning draws an important distinction: Zhang was seeking to use embryos created during her marriage, in pursuit of a reproductive plan already shared with her husband. She was not applying to begin treatment as an unmarried woman.

From fertility treatment to a dispute over continued care

Zhang and her husband, surnamed Li, married in 2016. They sought medical help after Zhang experienced repeated miscarriages and Li was diagnosed with secondary infertility, a term used when someone has previously achieved a pregnancy but later experiences difficulty doing so again.

The couple underwent ovarian stimulation at a Beijing hospital's reproductive center in March and May 2019. This treatment encourages eggs to develop so they can be collected for fertilization. Five eggs were retrieved, three were fertilized, and three embryos were successfully frozen.

The couple signed informed consent documents covering assisted reproductive treatment, in vitro fertilization and embryo transfer, and the freezing, thawing and transfer of embryos. In vitro fertilization involves fertilizing eggs outside the body; embryo transfer is the later procedure in which an embryo is placed in the uterus.

Li died of a brainstem hemorrhage in July 2019. Zhang subsequently underwent a transfer using one of the frozen embryos and gave birth to a daughter. Several years later, she asked the hospital to continue treatment with the two embryos still in storage.

The reported sequence of events is:

• 2016: Zhang and Li married.
• March and May 2019: Fertility treatment produced three embryos that were frozen.
• July 2019: Li died of a brainstem hemorrhage.
• After Li's death: Zhang used one embryo and gave birth to a daughter.
• Several years later: The hospital refused her request to use the remaining two embryos, prompting a lawsuit.
• September 22: The court publicly described the case during the release of its annual medical disputes white paper.

Why the hospital refused another transfer

The hospital said it had the medical capacity to perform the procedure. Its objections concerned authorization, contractual terms, family interests and ethics, rather than an identified inability to carry out embryo transfer.

One concern was that Li could no longer sign consent documents alongside Zhang. Another was the possibility that having another child would affect inheritance interests. The hospital also relied on a clause allowing embryos to be destroyed if either spouse died and said its ethics review had not approved further treatment.

China's rules governing human assisted reproductive technology restrict access to married couples and prohibit treatment for single women. The hospital argued that Li's death placed Zhang outside the category of patients eligible for the service.

The court acknowledged that the institution's concerns reflected a cautious approach to medical practice. It nevertheless found that those concerns did not justify refusing this particular request. The judges assessed whether the treatment was lawful, consistent with the couple's established wishes and ethically acceptable, and whether there was a practical obstacle to fulfilling the contract.

Why widowhood did not end this treatment contract

The court treated Zhang as an independent rights holder under the embryo transfer service contract. That finding meant her ability to seek performance of the agreement was not dependent solely on Li remaining alive and able to participate in every subsequent step.

The embryos had been created while the couple were married and pursuing a shared intention to have children. The judges found that Zhang's request did not contradict Li's wishes during his lifetime. His death did not, in their assessment, erase the reproductive intention the couple had already formed.

This reasoning addressed the hospital's reliance on restrictions affecting single women. The court distinguished a widow continuing treatment with embryos created during marriage from an unmarried woman seeking to initiate assisted reproductive treatment. It also found Zhang's request consistent with relevant population and family planning laws.

The hospital's earlier conduct mattered as well. It had already performed an embryo transfer for Zhang after Li's death, resulting in the birth of their daughter. The court considered its later reliance on her status as a single woman inconsistent with that earlier provision of care.

The ruling therefore rests on a specific combination of facts: an existing marriage when the embryos were created, a shared intention to have children, an established medical service relationship and a successful transfer after the husband's death. It does not establish unrestricted access to fertility treatment for every unmarried woman.

Inheritance concerns were checked and rejected

The hospital raised the possibility that Zhang wanted another child to obtain a larger share of Li's estate. The court examined that concern and found no unresolved inheritance dispute. Li's estate had already been settled through notarization and a settlement agreement.

That finding removed a concrete objection to continued treatment. The judgment did not need to resolve an active contest over estate distribution or decide competing claims between relatives. Its conclusion was that the inheritance concern raised by the hospital did not exist in this case.

Zhang's mother in law expressly supported her decision to continue using the embryos. Zhang also stated that she was willing to assume the legal, ethical and moral rights and obligations associated with embryo transfer and any resulting childbirth.

Family support was part of the court's assessment, alongside the couple's prior agreement and the settled estate. It was not described as replacing medical requirements or giving relatives a general power to authorize treatment. The court's reasoning brought these circumstances together rather than treating any one of them as sufficient on its own.

How the court balanced ethics and contractual duties

The dispute also involved ethical rules governing informed consent and the protection of children born through assisted reproduction. The court considered those requirements alongside the hospital's agreement to provide treatment and Zhang's request that it continue doing so.

The judges found that her request reflected her genuine wishes, did not violate laws or public order and good morals, and involved services the hospital was capable of performing. They concluded that there was no practical obstacle preventing continued embryo transfer.

Song Xiaopei, deputy chief judge of the court's Civil Division One, described the case as a typical dispute involving assisted reproductive treatment. Song explained that recognizing a widow as an independent contractual rights holder moved beyond treating her rights solely through the couple's joint status.

Song also connected the decision to the Civil Code's approach to extending protection of personality rights. The central point was that the couple had formed a clear intention to have children before Li died, and that intention did not disappear with his death.

The court's stated approach gives weight to legal limits, ethical justification, family agreement and good faith performance of contracts. In Zhang's case, those considerations supported continued care rather than cancellation of the treatment relationship.

Where the case fits in Chinese judicial practice

An academic article in Peking University Law Journal places this dispute within a wider pattern of Chinese litigation over frozen embryos. The frozen embryo study, titled Between emotion and reason: the judicial practice of disputes involving frozen embryos in China, was published online on March 12, 2025. It appears in Volume 12, Issue 1, dated 2024, on pages 83 to 99.

Its abstract identifies two main categories of disputes: requests for hospitals to return frozen embryos, and requests involving assisted reproduction after a partner's death. These are related but different claims. Obtaining embryos from storage does not necessarily mean a hospital has been ordered to provide a transfer procedure.

The article reports that Chinese courts tend to support surviving parties who seek access to embryos or continued embryo transfer after a partner dies. It also describes a tendency to protect private rights involving frozen embryos where courts do not consider their exercise harmful to the public interest.

The author suggests that traditional Confucian family ethics, ideas about continuity of bloodlines and changes in childbirth policy may help explain this judicial approach. Those are the study's proposed explanations for a broader pattern, not additional findings made by the Chaoyang court.

Zhang's judgment is consistent with the pattern described in the abstract. The academic account does not, however, establish that every similar claim succeeds or that courts apply identical reasoning in all circumstances.

What the ruling decides, and what remains unknown

The legally effective judgment requires the hospital to resume the relevant assisted reproductive treatment and in vitro fertilization and embryo transfer services. Zhang must pay the personally payable portion of the associated medical expenses. The order concerns access to treatment, not a guaranteed pregnancy or birth.

No date has been disclosed for the next transfer, and there is no reported outcome for either remaining embryo. The case also does not establish whether both embryos would be used in a single procedure or in separate attempts. Those details should not be inferred from the order to continue care.

The court included the dispute in its annual white paper as an example of new questions arising from reproductive technology. Its practical significance lies in recognizing that a surviving spouse may retain enforceable rights under an existing treatment agreement, even when death makes the hospital's usual consent process impossible.

The decision remains grounded in Zhang's circumstances. The shared reproductive plan, the embryos' creation during marriage, the earlier transfer, the settled estate and family support all contributed to the court's conclusion that treatment should continue.

Key Points

• Beijing's Chaoyang District People's Court ordered a hospital to resume fertility treatment for widow Zhang.
• Three embryos were frozen in 2019 before her husband Li died that July.
• Zhang later used one embryo and gave birth to a daughter; two embryos remained.
• The court recognized her independent rights under the medical service contract and distinguished her request from an unmarried woman beginning treatment.
• Li's estate had already been settled, and Zhang's mother in law supported further transfers.
• The judgment is legally effective, but no subsequent transfer date or pregnancy outcome has been disclosed.